ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Aerpio Pharmaceuticals Inc

Aerpio Pharmaceuticals Inc (ARPO)

2.20
0.00
(0.00%)
At close: 05 November 8:00AM
2.20
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.20
Bid
2.26
Offer
2.27
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
2.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
24,525,000
Dividend Yield
-
PE Ratio
-0.73
Earnings Per Share (EPS)
-2.68
Revenue
24.35M
Net Profit
-65.77M

About Aerpio Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

ARPO Latest News

Aravive Appoints Michael W. Rogers to Board of Directors

HOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc.Β (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics,Β today announced that Michael W...

Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-...

Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients PR Newswire SAN FRANCISCO and CINCINNATI, Sept...

Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ...

Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory...

Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (fo...

CINCINNATI, May 12, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (β€œAerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat...

Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020

CINCINNATI, March 12, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular...

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Pr...

Data presented at the 9th Annual Glaucoma 360 New Horizons Forum Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to...

Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperem...

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced...

Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperem...

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced...

Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported...

Aerpio Pharmaceuticals Announces Review of Strategic Alternatives

Aerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular disease and diabetic complications, today announced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPPLSIMPPLE Ltd
US$ 1.7999
(52.53%)
15.95M
BNOXBionomics Ltd
US$ 0.252
(31.77%)
7.92M
BCOVBrightcove Inc
US$ 2.7795
(29.88%)
314.21k
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 54.97
(25.76%)
95.12k
QNSTQuinStreet Inc
US$ 25.05
(24.01%)
26.04k
MQMarqeta Inc
US$ 4.07
(-31.60%)
2.72M
VRCAVerrica Parmaceuticals Inc
US$ 1.16
(-18.88%)
83.44k
SLABSilicon Labs
US$ 87.00
(-16.94%)
6.35k
VERBVerb Technology Company Inc
US$ 10.25
(-13.36%)
45.97k
TCMDTactile Systems Technology Inc
US$ 13.3109
(-11.91%)
3.77k
SPPLSIMPPLE Ltd
US$ 1.7999
(52.53%)
15.95M
IDAIT Stamp Inc
US$ 0.24
(-2.04%)
14.73M
ELABElevai Labs Inc
US$ 0.022
(9.45%)
13.2M
BNOXBionomics Ltd
US$ 0.252
(31.77%)
7.92M
NVDANVIDIA Corporation
US$ 136.12
(0.05%)
4.66M

ARPO Discussion

View Posts
Jaythesaabguy Jaythesaabguy 3 years ago
woops
πŸ‘οΈ0
Jaythesaabguy Jaythesaabguy 3 years ago
wrong board. please delete. my bad.
πŸ‘οΈ0
waterchaser waterchaser 3 years ago
Reverse split incoming.

https://www.otcmarkets.com/market-activity/corporate-actions

1:15
πŸ‘οΈ0
Disquisition Disquisition 3 years ago
this is about to DUMP like no one’s ever seen before
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
Could it be the higher price target is pricing in for the reverse split?

"Aerpio will ask its stockholders to approve an amended and restated certificate of incorporation, including to effect a reverse stock split of Aerpio common stock (referred to as the β€œreverse stock split”), which approval is also necessary to complete the transactions contemplated by the merger agreement. Upon the effectiveness of the amended and restated certificate of incorporation effecting the reverse stock split, the outstanding shares of Aerpio common stock will be combined into a lesser number of shares to be determined by Aerpio’s board of directors (referred to as the β€œAerpio Board”) prior to the effective time of such amended and restated certificate of incorporation and public announcement by Aerpio (referred to as the β€œcharter proposal” or β€œProposal 2”);"

http://archive.fast-edgar.com/20210708/AN22622EZC2R79Z2222L2ZYJE5RLOZ223232/

$ARPO
πŸ‘οΈ0
Roadtojourney Roadtojourney 3 years ago
This probably was a typo imo?? Or else who buy would junk like this except bagholders like me lol imo
πŸ‘οΈ0
Jaythesaabguy Jaythesaabguy 3 years ago
Looking like a lift before EOD
πŸ‘οΈ0
jjtcwine jjtcwine 3 years ago
NASDAQ: ARPO) from Neutral to Buy with a price target of $22.00. who knows// it is at 2.50 now.
πŸ‘οΈ0
jjtcwine jjtcwine 3 years ago
The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
Right on. This might turn into a long hold for me. It would be great to find a couple more analysts who agree with the price target.

$ARPO
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
I slapped it. We'll see how it goes.

$ARPO
https://t.co/oKnuQ0Cr4U— Frank T (@FrankT95842414) July 8, 2021

$ARPO
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
I saw this went over $3.00 today.
But I sold this and put my money into CARV...and I did okay.

I have this company on my radar.
πŸ‘οΈ0
suziedavis suziedavis 3 years ago
Nope now let's rumble up!!!
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
I guess the $22 was not a typo after all. The analyst calls the merger "transformational" for ARPO. WAtching for a dip.
https://pub.webull.com/us/news-html/8a64b3e29bf94bb6b757467ba2fd121d.html?theme=1&color=2&hl=en&android_sdk_int=28&canary-version=&_v=1&sp=1&tickerId=925347608&disSymbol=ARPO

$ARPO
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
I'm out as well. +$50 bucks lol. Have a green day!

$ARPO
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
I sold for a few hundred dollar profit.
I don't trust this -- the premarket trading scared me.

Please stay safe.
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
I'm in also. Good luck to you too.
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
It still might! That NEWS ($22 price target) on TDA screams buy! I did lol. The newS release has share structure and financing details. Perhaps that will attract some new buyers. I'm not savvy enough in biopharma companies to know. Good luck friend.

$ARPO
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
I was hoping this would have broke (at least) $3.00 today.
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
I see. Guess I'll trade out of this pig
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
Probably is a typo. Because they're heavily dumping shares on the news.
πŸ‘οΈ0
frankyahoo frankyahoo 3 years ago
WTH? THIS must be a typo? Took some. Good luck

$ARPO
πŸ‘οΈ0
jjtcwine jjtcwine 3 years ago
Announces $22 Price Target,HC Wainwright & Co. Upgrades Aerpio Pharmaceuticals to Buy
πŸ‘οΈ0
WWOE88 WWOE88 3 years ago
Hello-- Did this used to be under the symbol...AERP?

Thanks
πŸ‘οΈ0
ClayTrader ClayTrader 3 years ago
* * $ARPO Video Chart 05-19-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 3 years ago
* * $ARPO Video Chart 05-18-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 3 years ago
* * $ARPO Video Chart 05-17-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Docstemcell2020 Docstemcell2020 3 years ago
Nice
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
Nice merger news out
πŸ‘οΈ0
RNsidersbuying RNsidersbuying 4 years ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160265488
πŸ‘οΈ0
Dubster watching Dubster watching 4 years ago
Took a position today. Nice drop

GL
πŸ‘οΈ0
realfast95 realfast95 4 years ago
9/17/2020 HC Wainwright Reiterated Rating Hold $2.00
πŸ‘οΈ0
cheekitlim cheekitlim 4 years ago
$ARPO $2 AND BEYOND!!!

VACCINE UPCOMING!!!!!!
πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $ARPO Video Chart 08-05-2020 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
Horsts Horsts 4 years ago
No, sorry
πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
OH. OK. I THOUGHT YOU WERE THE ONE OFFLOADING ALL THOSE ARPO SHARES AFTERHOURS. LOL
πŸ‘οΈ0
Horsts Horsts 4 years ago
No matter, I’m out weeks ago
πŸ‘οΈ0
Horsts Horsts 4 years ago
But way ???
πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
ARPO FLYING AFTERHOURS
πŸ‘οΈ0
Horsts Horsts 4 years ago
Yep break out monstA huge power hour and all at it’s best
πŸ‘οΈ0
Horsts Horsts 4 years ago
Power hour
πŸ‘οΈ0
Horsts Horsts 4 years ago
Yeah it breaks, not out....., but....
πŸ‘οΈ0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
APRO looks great to break
πŸ‘οΈ0
Horsts Horsts 4 years ago
MonstA Hugeeee like Galaxy
πŸ‘οΈ0
Can'tSparTheGhost Can'tSparTheGhost 4 years ago
Good job, cheekitlim....Arpo should start to climb in rapid motion Monday.
πŸ‘οΈ0
Can'tSparTheGhost Can'tSparTheGhost 4 years ago
BINGO---100% BUY on BarCHART---wEEEEEEEEEEEEEEE!!!!!!!!!!!!

https://www.barchart.com/stocks/quotes/ARPO/opinion
πŸ‘οΈ0
Can'tSparTheGhost Can'tSparTheGhost 4 years ago
ARPO should have a lot of new eyes on it soon, sure enough. The Memorial week vacationers will be back in full force and read the news over the weekend.
πŸ‘οΈ0
Horsts Horsts 4 years ago
Those who bought yesterday are not as lucky than you
πŸ‘οΈ0
Sell4Profit Sell4Profit 4 years ago
$15m up front Gossamer Bio Inc plus $90m over the course of the contract. 
πŸ‘οΈ0